Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorJunbo Liang

About this trial

This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, perioperative complications, venous thromboembolism events, laboratory parameters, imaging outcomes, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies in elderly patients with unstable pelvic fragility fractures.

Eligibility criteria

Qualifiers

Age ≥ 60 years

Low energy trauma

Diagnosis of osteoporosis

Diagnosis of FFP3 or FFP4 fragility fractures of the pelvis

Disqualifiers

Severe open injury or skin infection at the surgical site

Hemodynamic instability preventing anesthesia or surgery

Severe psychiatric disorders or dementia

Severe obesity affecting imaging quality

Trial design

Treatments tested in this trial

  • Robot Assisted Minimally Invasive Fixation
  • Conventional Open Fixation

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Junbo Liang

Lead sponsor

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Sponsor institution